Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Argatroban in Pediatric Patients with HIT/HITTS
NCT00039858Phase 4Completed
- Sponsor
- Encysive Pharmaceuticals Inc.
- Start
- Sep 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of argatroban in heparin-induced thrombocytopenia (HIT), thrombosis, sponsored by Encysive Pharmaceuticals Inc.. Started Sep 2003; status: completed.
02
Drugs
argatroban
03
Conditions
heparin-induced thrombocytopenia (HIT)thrombosis
Beyond the preview
Go deeper on NCT00039858.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00039858.